Close X
Monday, November 25, 2024
ADVT 
International

Low H-1B visa limit affecting employers: Study

Darpan News Desk IANS, 03 Feb, 2023 11:47 AM
  • Low H-1B visa limit affecting employers: Study
Photo courtesy of IStock. 
 
New York, Feb 3 (IANS) The low annual limit for US H-1B work visa petitions is currently the main problem facing employers trying to secure foreign-born talent, according to a new research.

The H-1B visa denial rates have returned to low levels following the administration's losses in federal court during former President Donald Trump's last year in office, the National Foundation for American Policy (NFAP) said in a new study released on Thursday.

In April 2022, the US Citizenship and Immigration Services (USCIS) reported employers submitted over 483,000 H-1B registrations, almost 400,000 above the 85,000-annual limit for H-1B petitions.

The denial rate for (new) H-1B petitions for initial employment in FY 2022 was 2 per cent.

The rate declined during the final year of the Trump administration after judges declared many of its H-1B-related actions unlawful.

This led to a legal settlement and changes to restrictive immigration policies that resulted in the denial rate for new H-1B petitions for initial employment in FY 2021 dropping to 4 per cent -- far lower than the denial rate of 24 per cent in FY 2018, 21 per cent in FY 2019 and 13 per cent in FY 2020.

The research, based on data from the USCIS H-1B Employer Data Hub, also found that Amazon had the most approved H-1B petitions for initial employment in FY 2022, with 6,396, followed by Infosys (3,151) and TCS (2,725).

The 85,000 new H-1B petitions allowed each year for companies represent only 0.05 per cent of the approximately 165 million people in the US labor force.

An H-1B petition is often the only practical way to hire a high-skilled foreign national, including an international student.

At US universities, more than 70 per cent of full-time graduate students in electrical engineering and computer and information sciences are international students.

A 2022 NFAP study found 55 per cent of America's startup companies valued at $1 billion or more have at least one immigrant founder, illustrating the importance and contributions of immigrants to the US economy.

"Despite the end of the Trump administration's restrictive immigration policies that made US companies less competitive in the global battle for talent, companies in America still must deal with the low annual limit on H-1B petitions and employment-based green cards," said Stuart Anderson, NFAP's executive director.

"These and other policies encourage employers to send work and people outside the US and make it difficult for many talented people to pursue their dreams in America," he added.

 

MORE International ARTICLES

African scientists baffled by monkeypox cases in Europe, US

African scientists baffled by monkeypox cases in Europe, US
Cases of the smallpox-related disease have previously been seen only among people with links to central and West Africa. But in the past week, Britain, Spain, Portugal, Italy, U.S., Sweden and Canada all reported infections, mostly in young men who hadn’t previously traveled to Africa. 

African scientists baffled by monkeypox cases in Europe, US

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk